OR WAIT null SECS
September 03, 2009
Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...
An H1N1 vaccine developed by biopharmaceutical company Sinovac Biotech (Beijing, China) has passed the experts evaluation organized by the Chinese State Food and Drug Administration (SFDA) and the company is expected to obtain a production license before the week's end.
September 02, 2009
After years of promomting QbD concepts, FDA's ready to take action on nonconformers.
As new process validation guidelines emerge, industry needs to reinvent how it releases product.
September 01, 2009
The authors describe the various available technologies used in orally disintegrating tablets.
Combination products have been researched and administered for many years, some successfully and others not.
Combining drugs with synergistic mechanisms of action yields some indisputable benefits; improved efficacy, reduced dosing, enhanced patient compliance, to name just a few.
August 27, 2009
Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory affairs; more...
August 21, 2009
Researchers at the University of Illinois (US) have developed a cancer drug delivery system that reportedly kills target tumour cells, spares healthy cells and has effects that can be reversed to halt potentially hazardous side effects.
August 20, 2009
Researchers at the University of Illinois (Champaign) have developed a cancer drug delivery system that reportedly kills target tumor cells, spars healthy cells, and has effects that can be reversed to halt potentially hazardous side effects.